41 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Bcl11atm1Mbu/Bcl11atm1Mbu Eportm1.1(EGFP/icre)Uk/Epor+ Tg(HBB)8.1Gvs/0 involves: 129 * BALB/cJ * FVB/N	abnormal erythropoiesis	J:196405
	anemia	J:196405
	decreased erythrocyte cell number	J:196405
	decreased hematocrit	J:196405
	decreased hemoglobin content	J:196405
	increased circulating erythropoietin level	J:196405
	normal mortality/aging	J:196405
	reticulocytosis	J:196405
Bcl11atm1Mbu/Bcl11atm1Mbu Klf1tm1Nimr/Klf1+ Eportm1.1(EGFP/icre)Uk/Epor+ Tg(HBB)8.1Gvs/0 involves: 129P2/OlaHsd * BALB/cJ * FVB/N	abnormal erythropoiesis	J:196405
	polychromatophilia	J:196405
Bcl11atm1Pwt/Bcl11atm1Pwt Eportm1.1(EGFP/icre)Uk/Epor+ involves: BALB/cJ	normal hematopoietic system phenotype	J:196140
Bcl11atm1Pwt/Bcl11atm1Pwt Kdm1atm1.1Sho/Kdm1a+ Eportm1.1(EGFP/icre)Uk/Epor+ involves: 129 * BALB/cJ	anemia	J:196140
	decreased erythrocyte cell number	J:196140
	decreased hemoglobin content	J:196140
Dyrk3tm1Dowo/Dyrk3tm1Dowo Eportm2Jni/Eportm2Jni involves: 129P2/OlaHsd * C57BL/6 * FVB/N	abnormal stress erythropoiesis	J:144586
Eedtm1Sho/Eedtm1Sho Eportm1.1(EGFP/icre)Uk/Epor+ Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos involves: 129S1/Sv * 129X1/SvJ * BALB/cJ	abnormal erythropoiesis	J:154730
Eportm1.1(EGFP/icre)Uk/Epor+ Rasa3tm1.1Llp/Rasa3tm1.1Llp involves: 129S1/SvImJ * BALB/cJ * C57BL/6J	normal hematopoietic system phenotype	J:301035
Eportm1.1(EGFP/icre)Uk/Epor+ Rasa3tm1.1Llp/Rasa3tm1.3Llp involves: 129S1/SvImJ * BALB/cJ * C57BL/6J	normal hematopoietic system phenotype	J:301035
Eportm1.1Jtp/Eportm1.1Jtp involves: 129P2/OlaHsd * C57BL/6	preweaning lethality, complete penetrance	J:67205
Eportm1.2Jtp/Eportm1.2Jtp B6.129P2-Eportm1.2Jtp	abnormal retina outer plexiform layer morphology	J:291641
	decreased a-wave amplitude	J:291641
	decreased amacrine cell number	J:291641
	decreased b-wave amplitude	J:291641
	decreased retina rod cell number	J:291641
	decreased total retina thickness	J:291641
	increased amacrine cell number	J:291641
	thin retina inner plexiform layer	J:291641
	thin retina outer plexiform layer	J:291641
	normal vision/eye phenotype	J:291641
Eportm1.2Jtp/Eportm1.2Jtp involves: 129P2/OlaHsd * C57BL/6	decreased hematocrit	J:67205
	decreased spleen weight	J:67205
Eportm1.3Jtp/Epor+ involves: 129P2/OlaHsd * C57BL/6	no abnormal phenotype detected	J:67205
Eportm1.3Jtp/Eportm1.3Jtp involves: 129P2/OlaHsd * C57BL/6	preweaning lethality, complete penetrance	J:67205
Eportm1.4Jtp/Epor+ involves: 129P2/OlaHsd * C57BL/6	increased hematocrit	J:67205
	increased hemoglobin content	J:67205
	polycythemia	J:67205
Eportm1.4Jtp/Eportm1.4Jtp involves: 129P2/OlaHsd * C57BL/6	abnormal proerythroblast morphology	J:67205
	anisocytosis	J:67205
	increased hematocrit	J:67205
	microcytosis	J:67205
	polycythemia	J:67205
Il22ra1tm1.1Koll/Il22ra1tm1.1Koll Eportm1.1(EGFP/icre)Uk/Epor+ involves: BALB/cJ * C57BL/6	decreased physiological sensitivity to xenobiotic	J:305794
	increased erythrocyte cell number	J:305794
	increased erythroid progenitor cell number	J:305794
	increased hematocrit	J:305794
Kdm1atm1.1Sho/Kdm1atm1.1Sho Eportm1.1(EGFP/icre)Uk/Epor+ involves: 129 * BALB/cJ	abnormal erythropoiesis	J:201572
	abnormal liver morphology	J:201572
	abnormal proerythroblast morphology	J:201572
	decreased embryo size	J:201572
	decreased fetal derived definitive erythrocyte cell number	J:201572
	pale liver	J:201572
	reticulocytopenia	J:201572
Slc29a1tm2Msg/Slc29a1tm2Msg Eportm1.1(EGFP/icre)Uk/Epor+ involves: 129X1/SvJ * BALB/cJ	abnormal response to injury	J:244602
	decreased interleukin-6 secretion	J:244602
	decreased susceptibility to injury	J:244602